Unlock the heart's
hidden potential.

Bringing the science of magnetocardiography to the forefront of clinical relevance.

MCG Indications of Interest
TODAY'S CLINICAL CHALLENGE

It’s become apparent that the standard of care has changed.

the benefits of mcg

A science with over sixty years of clinical investigation.

Historically, the difficulties associated with implementing an MCG system have severely limited the number of applications in use today. CardioFlux has overcome these barriers of the past, and is poised to be easily integrated into clinical workflows.

More Holistic
MCG has been known to detect vortex currents that give no ECG signal, creating a better, more holistic view of the electrical activity in the heart.

Learn more →

No Physical Contact
MCG requires no physical contact with the skin, so any problems arising from skin-electrode contact can be avoided.

Learn more →

Better Information
MCGs have the potential to give extra information over and above ECGs since they can detect the magnetic field produced by currents in heart tissue.

Learn more →

🫶 Today's Clinical Challenge

The standard of care has changed.

In recent years and across numerous publications, the preponderance of evidence now seems to point towards a simple thesis: the patients who benefit most from treatment are those who have heart disease considered to be “functionally significant”.

Non-invasive

Fast & Easy

Rapid & Dynamic Results

🫶 The Clinical Reality

Don't choose between efficient & effective.

However, the clinical reality facing most physicians today is that detecting “functionally significant” heart disease is difficult because physicians must often decide between choosing a care pathway that is efficient versus one that might be considered more effective.

🫶 A New Standard of Care

Free from contrast, stress and radiation.

Free from the requirements of contrast, stress, or radiation, CardioFlux is a resting, non-contact, functional imaging diagnostic which can be performed, from patient encounter to report interpretation, in less than 10 minutes.

"Genetesis is striving to improve efficiency in ruling out and detecting heart disease through magnetocardiography (MCG), an imaging modality that measures magnetic fields produced by the natural electrical activity of the heart.

Joe Sasson, Ph.D

PEVP of MedAxiom Venture

HeadNulla vitae elit libero, a pharetra augue. Duis mollis, est non commodo luctus, nisi erat porttitor ligula, eget lacinia odio sem nec elit. Pus sit amet fermentum. Donec id elit non mi porta gravida at eget metus. Etiam porta sem malesuada magna mollis euismod.ing

Nulla vitae elit libero, a pharetra augue.

New York Times

🫶 Today's Clinical Challenge

Peer-reviewed studies around the world have demonstrated MCG’s ability to diagnose coronary artery disease (CAD).

ACEP 2021

Almost to no one’s surprise, Genetesis presented preliminary data at ACEP 2021 demonstrating similar results in CardioFlux’s ability to diagnose myocardial ischemia.In parallel to these developments, the clinical community’s understanding of heart disease has begun to pivot towards a focus on ischemic heart disease (IHD), which is inclusive of not just CAD, but of coronary microvascular disease (CMD) as well.

Learn more →

ESC 2022

Presented at the ESC 2022 meeting in Barcelona, a separate study demonstrated how the application of a different diagnostic algorithm to CardioFlux data measured from INOCA patients could diagnose CMD. The potential ability to meaningfully differentiate between the various underlying causes of myocardial ischemia (endothelial vs. epicardial) within a single scan would truly redefine the standard of care for the diagnosis and treatment of IHD.

Learn more →

CLINICAL TRIALS

Clinical evidence is a cornerstone of cardiology.

View Our TrialsMCG Literature